Company intelligence / Profile preview

AntoXa Corporation

Toronto, Ontario, Canadaantoxacorp.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

AntoXa is developing plant-made monoclonal antibodies and enzyme therapeutics as medical countermeasures for biological and chemical threats. Its lead program is a monoclonal antibody against ricin poisoning in preclinical development. The company also has recombinant ACE2 therapies targeting COVID‑19 in discovery stage. No clinical results have been reported yet.

Therapeutic areas
OtherInfectious Diseases
Modalities
Monoclonal antibodies (mAbs)EnzymesRecombinant proteins (plant-based)
Industry
Biotech
02

Drug pipeline

2 assets

recombinant butyrylcholinesterase

Preclinical

1 more asset in the full pipeline.

Request access →
03

Partnerships

SwiftPharma (collaboration on plant-made mAb against ricin)Defence Research & Development Canada / Canadian Department of National Defence (licensing and research collaboration)

Beyond the preview

Go deeper on AntoXa Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AntoXa Corporation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call